U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Real-World Evidence Strategy Lead - m/f/d, Dermatology, Germany

Clinical Research OperationsUpdated on Nov 14
Full-timeMonheim am Rhein, GermanyNo salary listed

About the Job

Requirements

  • An advanced degree in life sciences, medicine, epidemiology, statistics, or a related discipline is required.
  • At least eight years of relevant pharmaceutical industry experience is required.
  • Strong expertise in epidemiology, outcomes research, and real-world evidence methodologies is required.
  • Experience developing evidence strategies across clinical development, regulatory affairs, and market access is required.
  • Strong cross-functional leadership, influencing, communication, and stakeholder management skills are required, including experience leading teams.
  • Experience contributing to or leading Integrated Evidence roles is required.
  • Excellent written and spoken English, with proven scientific communication capabilities, is required.

Responsibilities

  • Develop strategic real-world evidence plans supporting clinical, regulatory, access, and patient needs.
  • Anticipate evidence gaps and identify innovative solutions across the product lifecycle.
  • Lead real-world evidence studies, ensuring quality, governance, timelines, and budget delivery.
  • Partner across functions to align evidence strategies and stakeholder requirements.
  • Build productive relationships with external experts, influencers, and research partners.
  • Lead and develop experts while supporting broader functional leadership and mentorship.

Desired Qualifications

  • Experience in Dermatology and Immunology is preferred.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs